ETN
87
3
BBY
50
-2
CSCO
64
3
CA
44
8
VFC
35
4
WY
37
-2
NRG
79
4
DUK
62
2
MDLZ
51
-2
DOW
56
-4
LH
58
2
NWS
88
7
HES
67
-3
LOW
61
3
CTAS
64
3
HP
32
-2
KMX
61
-3
MMM
35
2
SPG
66
2
JCI
44
3
ETN
87
3
BBY
50
-2
CSCO
64
3
CA
44
8
VFC
35
4
WY
37
-2
NRG
79
4
DUK
62
2
MDLZ
51
-2
DOW
56
-4
LH
58
2
NWS
88
7
HES
67
-3
LOW
61
3
CTAS
64
3
HP
32
-2
KMX
61
-3
MMM
35
2
SPG
66
2
JCI
44
3
Financhill
Back

Y-mAbs Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
39

YMAB
Y-mAbs Therapeutics

Last Price:
11.76
Seasonality Move:
11.04%
Sell
37

NBY
NovaBay Pharmaceuticals

Last Price:
0.12
Seasonality Move:
1.9%
Sell
39
Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics a Buy, Sell or Hold?

  • The current Y-mAbs Therapeutics [YMAB] share price is $12.18. The Score for YMAB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.10. The Score for NBY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

YMAB Stock Price Chart

What is Y-mAbs Therapeutics's stock price today?

  • The Y-mAbs Therapeutics share price today is $12.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.

YMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 33.38 Sell
Chaikin Money Flow: -156020 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.25 - 16.41) Sell
Bollinger Bands (100): (10.18 - 16.86) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 60.18 Buy
Chaikin Money Flow: 10209132 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.07 - 0.09) Buy
Bollinger Bands (100): (0.1 - 0.18) Sell

YMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.68 Sell
20-day SMA: 14.82 Sell
50-day SMA: 15.21 Sell
200-day SMA: 9.54 Buy
8-day EMA: 13.25 Sell
20-day EMA: 14.31 Sell
50-day EMA: 14.55 Sell
200-day EMA: 11.24 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.09 Buy
20-day SMA: 0.08 Buy
50-day SMA: 0.1 Buy
200-day SMA: 0.29 Sell
8-day EMA: 0.09 Buy
20-day EMA: 0.09 Buy
50-day EMA: 0.11 Sell
200-day EMA: 0.51 Sell

Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.29 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.

Y-mAbs Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):